Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
NCT ID: NCT01423838
Last Updated: 2011-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
500 participants
INTERVENTIONAL
2011-09-30
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder
NCT06024005
The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)
NCT01533597
Validation of a Real-time Urodynamic Measure of Urinary Urgency
NCT00909428
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
NCT01093534
Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients
NCT00985387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Solifenacin
Anticholinergic molecule used in the treatment of overactive bladder.
Solifenacin
5 mg, oral, once in a day
Oxybutynin
Anticholinergic molecule used in the treatment of overactive bladder.
Oxybutynin
5 mg, oral, three times in a day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Solifenacin
5 mg, oral, once in a day
Oxybutynin
5 mg, oral, three times in a day
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kocaeli University
OTHER
Akdeniz University
OTHER
Cukurova University
OTHER
Baskent University
OTHER
Ankara University
OTHER
University of Gaziantep
OTHER
Inonu University
OTHER
Gaziosmanpasa University
UNKNOWN
Kahramanmaras Sutcu Imam University
OTHER
Adana Numune Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Murat Api
Associate Professor, M.D., Ph.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Murat Api, M.D., Ph.D.
Role: STUDY_DIRECTOR
Turkish Republic Ministry of Health Adana Numune Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Turkish Republic Ministry of Health Adana Numune Training and Research Hospital
Adana, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Solifenacin vs Oxybutynin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.